Skip to main content

COVID-19 Vaccine-Related Axillary Adenopathy on Breast Imaging: Follow-Up Recommendations and Histopathologic Findings.

Publication ,  Journal Article
Nguyen, DL; Ambinder, EB; Myers, KS; Mullen, LA; Panigrahi, B; Oluyemi, E
Published in: AJR Am J Roentgenol
June 2022

This study describes 94 patients who presented with suspected COVID-19 vaccine-related axillary adenopathy on breast imaging. All biopsies recommended within 12 weeks of the second vaccine dose were benign. Among women not recommended for biopsy, the median interval between the second vaccine dose and ultrasound follow-up was 15.9 weeks. Three biopsies yielding malignant diagnoses were recommended 12.0-13.1 weeks after the second vaccine dose. Lengthening imaging follow-up to 12-16 weeks after the second dose may reduce unnecessary biopsy recommendations.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

AJR Am J Roentgenol

DOI

EISSN

1546-3141

Publication Date

June 2022

Volume

218

Issue

6

Start / End Page

997 / 998

Location

United States

Related Subject Headings

  • Vaccines
  • SARS-CoV-2
  • Nuclear Medicine & Medical Imaging
  • Lymphadenopathy
  • Humans
  • Follow-Up Studies
  • Female
  • COVID-19 Vaccines
  • COVID-19
  • Breast Neoplasms
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Nguyen, D. L., Ambinder, E. B., Myers, K. S., Mullen, L. A., Panigrahi, B., & Oluyemi, E. (2022). COVID-19 Vaccine-Related Axillary Adenopathy on Breast Imaging: Follow-Up Recommendations and Histopathologic Findings. AJR Am J Roentgenol, 218(6), 997–998. https://doi.org/10.2214/AJR.21.27162
Nguyen, Derek L., Emily B. Ambinder, Kelly S. Myers, Lisa A. Mullen, Babita Panigrahi, and Eniola Oluyemi. “COVID-19 Vaccine-Related Axillary Adenopathy on Breast Imaging: Follow-Up Recommendations and Histopathologic Findings.AJR Am J Roentgenol 218, no. 6 (June 2022): 997–98. https://doi.org/10.2214/AJR.21.27162.
Nguyen DL, Ambinder EB, Myers KS, Mullen LA, Panigrahi B, Oluyemi E. COVID-19 Vaccine-Related Axillary Adenopathy on Breast Imaging: Follow-Up Recommendations and Histopathologic Findings. AJR Am J Roentgenol. 2022 Jun;218(6):997–8.
Nguyen, Derek L., et al. “COVID-19 Vaccine-Related Axillary Adenopathy on Breast Imaging: Follow-Up Recommendations and Histopathologic Findings.AJR Am J Roentgenol, vol. 218, no. 6, June 2022, pp. 997–98. Pubmed, doi:10.2214/AJR.21.27162.
Nguyen DL, Ambinder EB, Myers KS, Mullen LA, Panigrahi B, Oluyemi E. COVID-19 Vaccine-Related Axillary Adenopathy on Breast Imaging: Follow-Up Recommendations and Histopathologic Findings. AJR Am J Roentgenol. 2022 Jun;218(6):997–998.

Published In

AJR Am J Roentgenol

DOI

EISSN

1546-3141

Publication Date

June 2022

Volume

218

Issue

6

Start / End Page

997 / 998

Location

United States

Related Subject Headings

  • Vaccines
  • SARS-CoV-2
  • Nuclear Medicine & Medical Imaging
  • Lymphadenopathy
  • Humans
  • Follow-Up Studies
  • Female
  • COVID-19 Vaccines
  • COVID-19
  • Breast Neoplasms